[HTML][HTML] Ten years of gadolinium retention and deposition: ESMRMB-GREC looks backward and forward
AJ van der Molen, CC Quattrocchi, CA Mallio… - European …, 2024 - Springer
In 2014, for the first time, visible hyperintensities on unenhanced T1-weighted images in the
nucleus dentatus and globus pallidus of the brain were associated with previous Gadolinium …
nucleus dentatus and globus pallidus of the brain were associated with previous Gadolinium …
Risks and benefits of gadolinium-based contrast-enhanced MRI
CM Costelloe, B Amini, JE Madewell - Seminars in Ultrasound, CT and MRI, 2020 - Elsevier
The responsible use of gadolinium-based contrast agents (GBCAs) requires a balance
between safety and clinical utility. While nephrogenic systemic fibrosis (NSF) has been …
between safety and clinical utility. While nephrogenic systemic fibrosis (NSF) has been …
[PDF][PDF] Comprehensive Analysis of the Spatial Distribution of Gadolinium, Iron, Manganese, and Phosphorus in the Brain of Healthy Rats After High-Dose …
L Hummel, T Frenzel, J Boyken, H Pietsch… - Investigative …, 2023 - journals.lww.com
Objectives After the administration of gadolinium-based contrast agents (GBCAs), residual
gadolinium (Gd) has been detected in a few distinct morphological structures of the central …
gadolinium (Gd) has been detected in a few distinct morphological structures of the central …
Gadolinium deposition in the brain is related to various contrast agents: a matched case–control study
Q Bi, H Li, J Du, Q Li, J Wang, Y Huang, X Gong - Clinical Radiology, 2022 - Elsevier
AIM To assess the relationship between gadolinium deposition in the brain and various
gadolinium-based contrast agents (GBCAs) and to explore confounding variables …
gadolinium-based contrast agents (GBCAs) and to explore confounding variables …
[HTML][HTML] T1-Weighted intensity increase after a single administration of a linear gadolinium-based contrast agent in multiple sclerosis
S Grahl, M Bussas, V Pongratz, JS Kirschke… - Clinical …, 2021 - Springer
Purpose Through analysis of T1-weighted (T1w) images this study investigated gadolinium
(Gd) deposition in the brain after administration of a linear (gadopentetic acid) and a cyclic …
(Gd) deposition in the brain after administration of a linear (gadopentetic acid) and a cyclic …
[PDF][PDF] Adverse effects of gadolinium-based contrast agents in organ systems: a literature review
D Andrijauskis, I Keturkaite - Journal of MEDICAL SCIENCES, 2019 - medicsciences.com
Background and aim: Gadolinium based contrast agents are widely used materials in
magnetic resonance imaging (MRI) diagnostic procedures. Gadolinium based contrast …
magnetic resonance imaging (MRI) diagnostic procedures. Gadolinium based contrast …
Utilização de Gadolínio nas Ressonâncias Magnéticas de Controlo em Doentes com Esclerose Múltipla: Recomendações Atuais
A Cruz, D Pereira, S Batista - Acta Médica Portuguesa, 2024 - actamedicaportuguesa.com
Multiple sclerosis is the most frequent demyelinating disease of the central nervous system
and is characterized by early onset and progressive disability. Magnetic resonance imaging …
and is characterized by early onset and progressive disability. Magnetic resonance imaging …
含钆造影剂脑内沉积的研究现状
刘金沙， 伍建林 - 大连医科大学学报, 2020 - journal.dmu.edu.cn
含钆造影剂(gadolinium-based contrast agents, GBCAs) 被广泛应用于磁共振增强检查,
尤其是神经系统疾病的检测与诊断. 过去多认为含钆造影剂是安全, 稳定的 …
尤其是神经系统疾病的检测与诊断. 过去多认为含钆造影剂是安全, 稳定的 …